Adage Capital Partners Gp, L.L.C. Moon Lake Immunotherapeutics Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,500,000 shares of MLTX stock, worth $19.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,500,000Holding current value
$19.2 Million% of portfolio
0.02%Shares
9 transactions
Others Institutions Holding MLTX
# of Institutions
165Shares Held
41.7MCall Options Held
2.58MPut Options Held
1.01M-
Bvf Inc San Francisco, CA19.8MShares$252 Million7.66% of portfolio
-
Avoro Capital Advisors LLC New York, NY2MShares$25.5 Million0.2% of portfolio
-
Cormorant Asset Management, LP Boston, MA1.99MShares$25.5 Million2.28% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.7MShares$21.7 Million0.02% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY965KShares$12.3 Million0.05% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $472M
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...